LASA SUPERGENERICS
Back to Income Statement
|
LASA SUPERGENERICS Last 5 Year Earnings Per Share (EPS) History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹-4.34 | ₹-7.71 | ₹-1.06 | ₹5.60 | ₹0.89 |
What is the latest Earnings Per Share (EPS) of LASA SUPERGENERICS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2024 | ₹-4.34 |
| Mar2023 | ₹-7.71 |
| Mar2022 | ₹-1.06 |
| Mar2021 | ₹5.60 |
| Mar2020 | ₹0.89 |
How is Earnings Per Share (EPS) of LASA SUPERGENERICS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2024 | ₹-4.34 | Negative | |
| Mar2023 | ₹-7.71 | Negative | |
| Mar2022 | ₹-1.06 | Negative | |
| Mar2021 | ₹5.60 | 529.21 | |
| Mar2020 | ₹0.89 | - | |
Compare Earnings Per Share (EPS) of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹29.9 Cr | -15.9% | -26.7% | -68.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -15.9% |
-26.7% |
-68.1% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses